secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXICURE, INC. (XCUR)
CIK:        0001698530
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001698530-22-000101
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.02, 5.07, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Exicure stockholders approve change-of-control private placement to CBI USA; two directors resign
--------------------------------------------------------------------------------

- Stockholders approved issuance of 3,400,000 shares at $1.60/share to CBI USA, resulting in change of control.
- Private placement expected to close no later than January 20, 2023, subject to customary conditions.
- Directors James Sulat and Bali Muralidhar resigned; effective earlier of closing or Dec 30, 2022.
- With resignations, audit committee will have only two independent directors, triggering Nasdaq non-compliance and cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1698530/000169853022000101/0001698530-22-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1698530/000169853022000101/xcur-20221215.htm
  HTML page:      https://secwatch.observer/filing/0001698530-22-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer